Aigh Capital Management LLC Bio Cardia, Inc. Transaction History

Aigh Capital Management LLC

  • $247 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$1.87 - $2.54 $160,980 - $218,658
-86,086 Reduced 14.46%
509,151 $992,000
Q4 2022

Feb 14, 2023
BUY
$1.61 - $32.1 $958,331 - $19.1 Million
595,237 New
595,237 $1.24 Million

About BioCardia, Inc.

BCDA Quotes by TradingView
  • Ticker BCDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,758,200
  • Market Cap $41.2M
  • Description
  • BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and chronic myocardial ischemia; and allogeneic cell therapy for cardiac and pulmonary di...
More about BCDA
Track This Portfolio

Track Aigh Capital Management LLC Portfolio

Follow Aigh Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aigh Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aigh Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email